Domains pointed to ns2.bms.com
These websites are known to have been using ns2.bms.com as their DNS nameserver.
Number of websites/domains displayed: 44
Results found: 44
Websites discovered:
YERVOY®(ipilimumab) | Consumer | Gatewayhttp://pageoverview.com/website-report/yervoy.com
YERVOY® (ipilimumab), prescription medication. See Indication, Important Safety Information, and Boxed Warning.
- Expected expiration: May 8th in 2018
- Creation date: May 8th in 2009
- Renew date: May 4th in 2017
Homepagehttp://pageoverview.com/website-report/bms.com.mx
Bristol-Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines that help patients prevail over serious diseases.
- Expected expiration: January 12th in 2018
- Creation date: January 13th in 2000
- Renew date: January 8th in 2017
Working Together For Patients | BMS Careers Irelandhttp://pageoverview.com/website-report/bmscareers.ie
Bristol-Myers Squibb is a global biopharma company helping millions of people around the world prevail over serious diseases. Join us as we expand further in Ireland.
Accueil | UPSA.comhttp://pageoverview.com/website-report/upsa.com
Le laboratoire pharmaceutique UPSA, implanté en France depuis 1935 a développé une forte expertise dans l'effervescence, le traitement de la douleur, les affections de la sphère ORL, la vitalité, la digestion et la qualité du sommeil.
- Expected expiration: April 1st in 2018
- Creation date: April 1st in 2002
- Renew date: March 28th in 2017
- Google Analytics: 63105149-2
kanen.jphttp://pageoverview.com/website-report/kanen.jp
- Expected expiration: April 30th in 2018
- Creation date: April 25th in 2013
- Renew date: May 1st in 2017
ORENCIA® (abatacept) | Official Patient Websitehttp://pageoverview.com/website-report/orencia.com
The ORENCIA® (abatacept) site provides Important Safety Information and Full Prescribing Information. Visit orencia.bmscustomerconnect.com to learn more
- Expected expiration: January 24th in 2018
- Creation date: January 24th in 2001
- Renew date: January 20th in 2017
OPDIVO® (nivolumab) | Patient Gatewayhttp://pageoverview.com/website-report/opdivo.com
OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.
- Expected expiration: November 6th in 2017
- Creation date: November 6th in 2012
- Renew date: November 1st in 2016
もっと知ろう！B型肝炎情報：B型肝炎の疾患情報 | 肝炎.nethttp://pageoverview.com/website-report/bkanen.net
B型肝炎の疾患情報、検査から治療法、日常生活で気をつけること、妊娠を希望される場合の留意点やキャリアの方の出産についてまで、B型肝炎について、もっと知っていただくための情報をお届けします。肝炎患者さんのための情報サイト【肝炎.net】
- Expected expiration: November 2nd in 2017
- Creation date: November 2nd in 2005
- Renew date: October 29th in 2016
- Google Analytics: 24242236-11
Resourceshttp://pageoverview.com/website-report/bmscustomerconnect.com
- Expected expiration: April 29th in 2017
- Creation date: April 29th in 2014
- Renew date: April 24th in 2016
OPDIVO® (nivolumab) | Patients | Advanced Urothelial Carcinoma (Bladder Cancer)http://pageoverview.com/website-report/opdivoinformation.com
Information for consumers about OPDIVO® (nivolumab), a prescription medicine for previously treated bladder cancer (urothelial carcinoma) that has spread or grown. See Indication and Important Safety Information.
- Expected expiration: October 10th in 2018
- Creation date: October 10th in 2016
- Renew date: October 6th in 2017
Learn More About AFib-Related Stroke Risk | Tune in to AFibhttp://pageoverview.com/website-report/tuneintoafib.com
Are you in tune with AFib-related stroke risk? Explore information about stroke risk due to AFib (atrial fibrillation) not caused by a heart valve problem.
- Expected expiration: April 11th in 2018
- Creation date: April 11th in 2017
- Renew date: April 11th in 2017
BMS Loginhttp://pageoverview.com/website-report/globe-bms.com
- Expected expiration: October 30th in 2018
- Creation date: October 30th in 2013
- Renew date: October 26th in 2017
Homepagehttp://pageoverview.com/website-report/bms.it
Bristol-Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines that help patients prevail over serious diseases.
- Expected expiration: June 1st in 2017
- Creation date: May 24th in 1996
- Renew date: June 1st in 2016
Bristol-Myers Squibb | Homehttp://pageoverview.com/website-report/bristol.com.br
- Expected expiration: May 20th in 2019
- Creation date: May 20th in 1996
- Renew date: April 20th in 2017
- Google Analytics: 40942185-1
bmspaf.orghttp://pageoverview.com/website-report/bmspaf.org
- Expected expiration: October 8th in 2018
- Creation date: October 8th in 2002
- Renew date: October 4th in 2017
sprycel.jphttp://pageoverview.com/website-report/sprycel.jp
- Expected expiration: May 31st in 2017
- Creation date: May 24th in 2007
- Renew date: June 1st in 2016
HIV.de | Startseitehttp://pageoverview.com/website-report/hiv.de
Erfahren Sie auf hiv.de alles zum Thema HIV und AIDS. Wir informieren Sie unter anderem über die Therapie & das Leben mit HIV im Beruf und Alltag.
- Renew date: May 6th in 2016
SPRYCEL® (dasatinib) | SPRYCEL.comhttp://pageoverview.com/website-report/sprycel.com
Learn about SPRYCEL® (dasatinib)
- Expected expiration: July 1st in 2017
- Creation date: July 1st in 2002
- Renew date: June 27th in 2016
bmshealthcare.jphttp://pageoverview.com/website-report/bmshealthcare.jp
- Expected expiration: June 30th in 2017
- Creation date: June 3rd in 2013
- Renew date: July 1st in 2016
eliquis.jphttp://pageoverview.com/website-report/eliquis.jp
- Expected expiration: October 31st in 2017
- Creation date: October 4th in 2011
- Renew date: November 1st in 2016
b-ms.co.ukhttp://pageoverview.com/website-report/b-ms.co.uk
- Renew date: February 2nd in 2018
OPDIVO® (nivolumab) | HCP | Metastatic Urothelial Carcinoma (mUC)http://pageoverview.com/website-report/opdivoinformationhcp.com
OPDIVO® (nivolumab), for treatment of patients with previously treated locally advanced or metastatic urothelial carcinoma. See Indication and Important Safety Information.
- Expected expiration: October 10th in 2018
- Creation date: October 10th in 2016
- Renew date: October 6th in 2017
immunooncology.behttp://pageoverview.com/website-report/immunooncology.be
- Creation date: May 13th in 2011
SPRYCEL (dasatinib) for Healthcare Professionalshttp://pageoverview.com/website-report/sprycel-hcp.com
Find the latest safety and efficacy data for SPRYCEL® (dasatinib) for adult and pediatric patients. Visit SPRYCEL-hcp.com for more information.
- Expected expiration: March 31st in 2018
- Creation date: March 31st in 2010
- Renew date: March 27th in 2017
Accueil | UPSA nosproduitshttp://pageoverview.com/website-report/upsa-nosproduits.com
Depuis 1935, UPSA est spécialiste du traitement contre la douleur et a développé une large gamme d'automédication. Affections de la sphère ORL, digestions difficiles, troubles du sommeil: UPSA vous accompagne au quotidien!
- Expected expiration: September 21st in 2017
- Creation date: September 21st in 2015
- Renew date: September 17th in 2016
- Google Analytics: 63105149-3
OPDIVO® (nivolumab) | Information for Healthcare Professionalshttp://pageoverview.com/website-report/opdivohcp.com
Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.
- Expected expiration: March 3rd in 2018
- Creation date: March 3rd in 2014
- Renew date: February 27th in 2017
immunooncology.comhttp://pageoverview.com/website-report/immunooncology.com
- Expected expiration: March 30th in 2018
- Creation date: March 30th in 2012
- Renew date: March 26th in 2017
Bristol-Myers Squibb - Global Biopharmaceutical Companyhttp://pageoverview.com/website-report/bms.com
Learn more about Bristol-Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.
- Expected expiration: April 6th in 2018
- Creation date: April 5th in 1991
- Renew date: April 2nd in 2017
Medicin, behandling och forskning inom läkemedel: Bristol-Myers Squibbhttp://pageoverview.com/website-report/bms.se
Bristol-Myers Squibb utvecklar medicin och behandling av sjuka för att förbättra liv. Bolaget bedriver framtidsinriktad forskning för effektiva läkemedel.
- Creation date: March 22nd in 1997
- Expected expiration: December 31st in 2017
- Google Analytics: 89313735-2
shdevr.orghttp://pageoverview.com/website-report/shdevr.org
- Expected expiration: September 11th in 2018
- Creation date: September 11th in 2016
- Renew date: September 11th in 2017
Official Healthcare Professional Site | ORENCIA® (abatacept)http://pageoverview.com/website-report/orenciahcp.com
Our site offers info for healthcare providers treating patients with moderate to severe rheumatoid arthritis. See Important Safety Info and Prescribing Info.
- Expected expiration: March 2nd in 2018
- Creation date: March 2nd in 2015
- Renew date: February 26th in 2017
資格確認 | ONO MEDICAL NAVIhttp://pageoverview.com/website-report/immunooncology.jp
小野薬品工業株式会社が提供する情報サイト『ONOメディカルナビ』は、医療関係者の方に情報提供することを目的として作成しております。医療関係者以外の方への情報提供を目的としたものではありませんのでご了承ください。
- Expected expiration: July 31st in 2017
- Creation date: July 23rd in 2013
- Renew date: August 1st in 2016
eliquis.comhttp://pageoverview.com/website-report/eliquis.com
- Expected expiration: March 13th in 2018
- Creation date: March 13th in 2002
- Renew date: March 9th in 2017
kanen-net.infohttp://pageoverview.com/website-report/kanen-net.info
- Expected expiration: February 3rd in 2018
- Creation date: February 3rd in 2014
- Renew date: January 30th in 2017
EMPLICITI™ (elotuzumab)http://pageoverview.com/website-report/empliciti.com
Learn about EMPLICITI™ (elotuzumab) treatment which includes information about ongoing support and resources.
- Expected expiration: April 22nd in 2018
- Creation date: April 22nd in 2009
- Renew date: April 18th in 2017
ELIQUIS (apixaban)http://pageoverview.com/website-report/eliquis.no
- Creation date: March 3rd in 2011
- Renew date: March 3rd in 2017
- Google Analytics: 50716600-1
COUMADIN® | What is COUMADIN®http://pageoverview.com/website-report/coumadin.com
Learn about COUMADIN®, a prescription medicine. Read Important Safety Information and access Prescribing Information including BOXED WARNING and Medication Guide.
- Expected expiration: January 19th in 2018
- Creation date: January 18th in 1997
- Renew date: January 15th in 2017
orencia.jphttp://pageoverview.com/website-report/orencia.jp
- Expected expiration: August 31st in 2017
- Creation date: August 23rd in 2005
- Renew date: September 1st in 2016
Auf Herz & Venen - Vorhofflimmern und venöse Thromboembolien besser verstehenhttp://pageoverview.com/website-report/auf-herz-und-venen.de
Sie möchten Vorhofflimmern und venöse Thromboembolien besser verstehen? Nutzen Sie unser interaktives Herz- und Venenmodell, um im Detail zu sehen, wie sich das Herz bei Vorhofflimmern verhält. Erfahren Sie mehr über die Diagnose und die Therapie.
- Renew date: March 27th in 2017